CA
AMGN icon

Continental Advisors’s Amgen AMGN Stock Holding History

Continental Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,500
Closed -$393K – 145
2015
Q3 		$346K Sell
2,500
-500
-17% -$78.8K 0.09% 143
2015
Q2 		$461K Buy
+3,000
New +$481K 0.12% 125
2015
Q1 		– Sell
-1,100
Closed -$173K – 148
2014
Q4 		$175K Buy
+1,100
New +$171K 0.04% 148

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Continental Advisors's AMGN Position: Q4 2015 in Review

Continental Advisors sold out of Amgen (AMGN) in Q4 2015, closing a stake of 2,500 shares — an estimated $393K sold.

Continental Advisors first reported a position in AMGN in Q4 2014 and held it in 3 quarters. The position peaked at $461K in Q2 2015. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • Continental Advisors reported no remaining Amgen position as of Q4 2015 after selling out during the quarter.
  • Continental Advisors sold 2,500 Amgen shares in Q4 2015, an estimated $393K.
  • Continental Advisors first reported a position in Amgen in Q4 2014 and held it in 3 quarters.
  • Continental Advisors's Amgen position peaked at $461K in Q2 2015.
  • 1,453 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on Continental Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.